Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus

Human Immunology

Volumn 59, Issue 9, 1998, Pages 549-560

  Tabata, Hiroki ^a,b   Kanai, Takayuki ^a   Yoshizumi, Hideyuki ^c   Nishiyama, Soroku ^b   Fujimoto, Shigehiro ^d   Matsuda, Ichiro ^b   Yasukawa, Masaki ^e   Matsushita, Sho ^a   Nishimura, Yasuharu ^a  

^a Division of Immunogenetics   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^d Kokuritsu Miyakonojo Hospital   (Japan)

^e EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; GLUTAMATE DECARBOXYLASE; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; B LYMPHOBLAST; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE CLONE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HLA ANTIGENS; HUMANS; JAPAN; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS;

EID: 0031716214     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00050-0     Document Type: Article

References (50)

1. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69.
2. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72.
3. Baekkeskov S., Landin M., Kristensen J.K., Srikanta S., Bruining G.J., Mandrup-Poulsen T., de Beaufort C., Soeldner J.S., Eisenbarth G., Lindgren F., Sundkvist G., Lernmark A. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest. 79:1987;926.
4. Karlsen A.E., Hagopian W.A., Petersen J.S., Boel E., Dyrberg T., Grubin C.E., Michelsen B.K., Madsen O.D., Lernmark A. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies. Diabetes. 41:1992;1355.
5. Atkinson M.A., Kaufman D.L., Campbell L., Gibbs K.A., Shah S.C., Bu D.F., Erlander M.G., Tobin A.J., Maclaren N.K. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet. 339:1992;458.
6. Chervonsky A.V., Wang Y., Wong F.S., Visintin I., Flavell R.A., Janeway C.A. Jr, Matis L.A. The role of Fas in autoimmune diabetes. Cell. 89:1997;17.
7. Itoh N., Imagawa A., Hanafusa T., Waguri M., Yamamoto K., Iwahashi H., Moriwaki M., Nakajima H., Miyagawa J., Namba M., Makino S., Nagata S., Kono N., Matsuzawa Y. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med. 186:1997;613.
8. Todd J.A., Bell J.I., McDevitt H.O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 329:1987;599.
9. Durinovic-Bello I., Steinle A., Ziegler A.G., Schendel D.J. HLA-DQ-restricted, islet-specific T-cell clones of a type I diabetic patient T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice . Diabetes. 43:1994;1318.
10. Endl J., Otto H., Jung G., Dreisbusch B., Donie F., Stahl P., Elbracht R., Schmitz G., Meinl E., Hummel M., Ziegler A.G., Wank R., Schendel D.J. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest. 99:1997;2405.
11. Aparicio J.M., Wakisaka A., Takada A., Matsuura N., Aizawa M. HLA-DQ system and insulin-dependent diabetes mellitus in Japanese does it contribute to the development of IDDM as it does in Caucasians? Immunogenetics. 28:1988;240.
12. Definition, diagnosis, and classification. Technical Report Series 727. 1985;World Health Organization, Geneva.
13. Karlsen A.E., Hagopian W.A., Grubin C.E., Dube S., Disteche C.M., Adler D.A., Barmeier H., Mathewes S., Grant F.J., Foster D., Lernmrak A. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA. 88:1991;8337.
14. Chen Y.Z., Matsushita S., Nishimura Y. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation . J Immunol. 157:1996;3783.
15. Sone T., Tsukamoto K., Hirayama K., Nishimura Y., Takenouchi T., Aizawa M., Sasazuki T. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules. J Immunol. 135:1985;1288.
16. Robbins P.A., Evans E.L., Ding A.H., Warner N.L., Brodsky F.M. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes. Hum Immunol. 18:1987;301.
17. Watson A.J., DeMars R., Trowbridge I.S., Bach F.H. Detection of a novel human class II HLA antigen. Nature. 304:1983;358.
18. Inoko H., Bodmer J.G., Heyes J.M., Drover S., Trowsdale J., Marshall W.H. Joint report on the transfectant/monoclonal antibody component. Tsuji K., Aizawa M., Sasazuki T. HLA 1991 Proceedings of the 11th International Histocompatibility Workshop and Conference . 1:1992;Oxford University Press, Oxford.
19. Ikagawa S., Matsushita S., Chen Y.Z., Ishikawa T., Nishimura Y. Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j 1)-derived peptide induced alterations in human T cell responses and T cell receptor antagonism. J Allergy Clin Immun. 97:1996;53.
20. + T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms. Eur J Immunol. 28:1998;305.
21. Kimura A., Dong R.P., Harada H., Sasazuki T. DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. Tsuji K., Aizawa M., Sasazuki T. HLA 1991 Proceedings of the 11th International Histocompatibility Workshop and Conference . 1:1992;Oxford University Press, Oxford.
22. Kasahara Y., Wada T., Niida Y., Yachie A., Seki H., Ishida Y., Sakai T., Koizumi F., Koizumi S., Miyawaki T., Taniguchi N. Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder. Int Immunol. 10:1998;195.
23. Kimura A., Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. Tsuji K., Aizawa M., Sasazuki T. HLA 1991 Proceedings of the 11th International Histocompatibility Workshop and Conference . 1:1992;Oxford University Press, Oxford.
24. Bodmer J.G., Marsh S.G.E., Albert E.D., Bodmer W.F., Bontrop R.E., Charron D., Dupont B., Erlich H.A., Fauchet R., Mach B., Mayr W.R., Parham P., Sasazuki T., Schreuder G.M.Th., Strominger J.L., Svejgaard A., Terasaki P.I. Nomenclature for factors of the HLA system. Charron D. Proceedings of the Twelfth International Histocompatibility Workshop and Conference. I:1996;Medical and Science International Publisher, Paris.
25. Naruse T.K., Ando R., Nose Y., Kagiya M., Ando H., Kawata H., Nabeya N., Isshiki G., Inoko H. HLA-DRB4 genotyping by PCR-RFLP diversity in the associations between HLA-DRB4 and DRB1 alleles . Tissue Antigens. 49:1997;152.
26. Yamashita K., Cram D.S., Harrison L.C. Molecular cloning of full-length glutamic acid decarboxylase 67 from human pancreas and islets. Biochemi Biophys Res Comm. 192:1993;1347.
27. + T cells . J Exp Med. 166:1987;823.
28. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol. 140:1988;52.
29. Panina-Bordignon P., Lang R., van Endert P.M., Benazzi E., Felix A.M., Pastore R.M., Spinas G.A., Sinigaglia F. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med. 181:1995;1923.
30. Wong F.S., Visintin I., Wen L., Flavell R.A., Janeway C.A. Jr. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med. 183:1996;67.
31. Svejgaard A., Platz P., Ryder L.P. HLA and disease 1982 - a survey. Immunol Rev. 70:1983;193.
32. Svejgaard A., Ryder L.P. HLA and insulin-dependent diabetes an overview . Genet Epidemiol. 6:1989;1.
33. Ito M., Tanimoto M., Kamura H., Yoneda M., Morishima Y., Takatsuki K., Itatsu T., Saito H. Association of HLA-DR phenotypes and T-lymphocyte-receptor beta-chain-region RFLP with IDDM in Japanese. Diabetes. 37:1988;1633.
34. Acha-Orbea H., McDevitt H.O. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. Proc Natl Acad Sci USA. 84:1987;2435.
35. Hattori M., Buse J.B., Jackson R.A., Glimcher L., Dorf M.E., Minami M., Makino S., Moriwaki K., Kuzuya H., Imura H., Strauss W.M., Seidman J.G., Eisenbarth G.S. The NOD mouse recessive diabetogenic gene in the major histocompatibility complex . Science. 231:1986;733.
36. Nishimoto H., Kikutani H., Yamamura K., Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature. 328:1987;432.
37. NOD to the development of insulitis in non-obese diabetic mice. Nature. 345:1990;722.
38. + T cells of non-obese diabetic mice. J Immunol. 151:1993;1723.
39. Lohmann T., Leslie R.D., Hawa M., Geysen M., Rodda S., Londei M. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet. 343:1994;1607.
40. Atkinson M.A., Bowman M.A., Campbell L., Darrow B.L., Kaufman D.L., Maclaren N.K. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest. 94:1994;2125.
41. Yamagata K., Hanafusa T., Nakajima H., Sada M., Amemiya H., Tomita K., Miyagawa J., Noguchi T., Tanaka T., Kono N., Tarui S. HLA-DP and susceptibility to insulin-dependent diabetes mellitus in Japanese. Tissue Antigens. 38:1991;107.
42. O'Sullivan D., Arrhenius T., Sidney J., Del Guercio M.F., Albertson M., Wall M., Oseroff C., Southwood S., Colon S.M., Gaeta F.C., Sette A. On the interaction of promiscuous antigenic peptides with different DR alleles Identification of common structural motifs . J Immunol. 147:1991;2663.
43. Kaufman D.L., Erlander M.G., Clare-Salzler M., Atkinson M.A., Maclaren N.K., Tobin A.J. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest. 89:1992;283.
44. Campbell I.L., Iscaro A., Harrison L.C. IFN-gamma and tumor necrosis factor-alpha Cytotoxicity to murine islets of Langerhans . J Immunol. 141:1988;2325.
45. Hultgren B., Huang X., Dybdal N., Stewart T.A. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes. 45:1996;812.
46. Bottazzo G.F., Dean B.M., McNally J.M., MacKay E.H., Swift P.G., Gamble D.R. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med. 313:1985;353.
47. Herold K.C., Vezys V., Koons A., Lenschow D., Thompson C., Bluestone J.A. CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocin. J Immunol. 158:1997;984.
48. Conrad B., Weissmahr R.N., Boni J., Arcari R., Schupbach J., Mach B. A human endogenous retroviral superantigen as candidate autoimmmune gene in type I diabetes. Cell. 90:1997;303.
49. Azuma M., Cayabyab M., Buck D., Phillips J.H., Lanier L.L. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med. 175:1992;353.
50. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol. 11:1993;729.